LONDON, May 30, 2024 /PRNewswire/ — Soterios Pharma, a privately held clinical-stage pharmaceutical company, today announced positive topline results from its…
Moderate Alopecia AreataSoterios Pharma, a privately held clinical-stage pharmaceutical company, today announced positive topline results from its randomised, placebo-controlled, multi-dose Phase II trial evaluating STS-01 as a treatment for mild / moderate AA. Once-daily topical treatment of mild / moderate alopecia areata (AA) .
A systematic review presented at AAPA 2024 showed insignificant differences in treatment outcomes between oral JAK inhibitors and oral steroids based on alopecia outcomes like SALT.
Risankizumab Effective for Psoriasis Over 18 Months in Real World Settings hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.